Rapivab (peramivir) / Shionogi, BioCryst  >>  Phase 3
Welcome,         Profile    Billing    Logout  

8 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rapivab (peramivir) / BioCryst
NCT00486980 / 2007-002527-32: Intramuscular Peramivir for the Treatment of Uncomplicated Influenza

Withdrawn
3
RoW
Peramivir 150mg, Peramivir 300mg
BioCryst Pharmaceuticals
Influenza
 
 
NCT00610935: Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza

Terminated
3
82
US
Peramivir, Placebo
BioCryst Pharmaceuticals
Influenza
02/08
02/08
NCT00957996: Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza

Completed
3
234
US, Canada, RoW
Peramivir
BioCryst Pharmaceuticals, Department of Health and Human Services
Seasonal Influenza, Cough, Sore Throat, Nasal Congestion, Myalgia, Headache, Fatigue
10/10
08/11
NCT01224795: A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.

Terminated
3
1
US
Peramivir, Placebo Comparator
BioCryst Pharmaceuticals, Department of Health and Human Services
Influenza
11/10
11/10
NCT00958776 / 2009-012367-34: A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza

Terminated
3
405
US, Canada, Europe, RoW
Peramivir+SOC, Placebo+SOC
BioCryst Pharmaceuticals, Department of Health and Human Services
Cough, Sore Throat, Nasal Congestion, Headache, Fever, Seasonal Influenza
11/12
10/13
NCT02635724: Safety, PK and Effectiveness of IV Peramivir in Elderly and Higher Risk Subjects With Uncomplicated Influenza

Completed
3
74
US
Peramivir, Rapivab
BioCryst Pharmaceuticals
Influenza
04/18
09/18
BCX1812-305, NCT02369159 / 2021-001018-13: Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza

Completed
3
137
US, RoW
Peramivir, Oseltamivir
BioCryst Pharmaceuticals
Influenza
10/19
05/20
NCT02665351: Peramivir Treatment Response in Adults Hospitalized for Influenza-associated Lower Respiratory Tract Infections

Completed
2/3
16
RoW
Peramivir, intravenous neuraminidase inhibitor
Chinese University of Hong Kong, BioCryst Pharmaceuticals
Influenza
03/14
03/14

Download Options